PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20641565-3	2004	For enhanced efficacy, radionuclide-coupled anti-CD20 Abs tositumomab ((131)I labeled) or ibritumomab ((90)Y conjugated) were also respectively approved by the FDA for the treatment of NHL and are commercially available in the United States.	Radioisotopes	23-35	keratin 20	Homo sapiens	49-53	
20641768-3	2004	For enhanced efficacy, radionuclide-coupled anti-CD20 Abs tositumomab ((131)I labeled) or ibritumomab ((90)Y conjugated) were also respectively approved by the FDA for the treatment of NHL and are commercially available in the United States.	Radioisotopes	23-35	keratin 20	Homo sapiens	49-53	
17287964-4	2007	Encouraging results were also reported from monoclonal anti-CD20 antibodies, which are conjugated to radionuclides and exploit the high radiosensitivity of lymphomas.	Radioisotopes	101-114	keratin 20	Homo sapiens	60-64	
15815716-0	2005	Improved therapy of non-Hodgkin"s lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody.	Radioisotopes	60-73	keratin 20	Homo sapiens	102-106